| CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
OR2H1 |
OR2H1, OR2H6, OR2H8: Olfactory receptor 2H1 |
0.25 |
Evidence |
|
| DCBLD2 |
DCBLD2, CLCP1, ESDN: Discoidin, CUB and LCCL domain-containing protein 2 precurs |
PRRG3 |
PRRG3, TMG3: Transmembrane gamma-carboxyglutamic acid protein 3 precursor |
0.25 |
Evidence |
|
| CCL17 |
CCL17, SCYA17, TARC: Small-inducible cytokine A17 precursor |
NMUR1 |
GPR66, NMUR1: Neuromedin-U receptor 1 |
0.25 |
Evidence |
|
| AMHR2 |
AMHR2, AMHR: Anti-Muellerian hormone type-2 receptor precursor |
GDF2 |
GDF2, BMP9: Growth/differentiation factor 2 precursor |
0.25 |
Evidence |
|
| CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
GPR52 |
GPR52: Probable G-protein coupled receptor 52 |
0.25 |
Evidence |
|
| CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
GPR173 |
GPR173, SREB3: Probable G-protein coupled receptor 173 |
0.25 |
Evidence |
|
| OR7C1 |
OR7A5: Olfactory receptor 7A5 |
CCL27 |
CCL27, ILC, SCYA27: Small-inducible cytokine A27 precursor |
0.25 |
Evidence |
|
| OR7C1 |
OR7A5: Olfactory receptor 7A5 |
CCL17 |
CCL17, SCYA17, TARC: Small-inducible cytokine A17 precursor |
0.25 |
Evidence |
|
| PDK3 |
PDK3: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial precu |
MASS1 |
GPR98, KIAA0686, MASS1, VLGR1: G-protein coupled receptor 98 precursor |
0.25 |
Evidence |
|
| ACVR2B |
ACVR2B: Activin receptor type-2B precursor |
NODAL |
NODAL: Nodal homolog precursor |
0.25 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
GPR173 |
GPR173, SREB3: Probable G-protein coupled receptor 173 |
0.25 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
OR2H1 |
OR2H1, OR2H6, OR2H8: Olfactory receptor 2H1 |
0.25 |
Evidence |
|
| CRADD |
CRADD, RAIDD: Death domain-containing protein CRADD |
AIM2 |
AIM2: AIM2 protein |
0.25 |
Evidence |
|
| CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
GPR44 |
GPR44, CRTH2, DL1R: Putative G-protein coupled receptor 44 |
0.25 |
Evidence |
|
| CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
GPR22 |
GPR22: Probable G-protein coupled receptor 22 |
0.25 |
Evidence |
|
| CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
GPR19 |
GPR19: Probable G-protein coupled receptor 19 |
0.25 |
Evidence |
|
| TGFB2 |
TGFB2: Transforming growth factor beta-2 precursor |
ACVR2B |
ACVR2B: Activin receptor type-2B precursor |
0.25 |
Evidence |
|
| CCL18 |
CCL18, AMAC1, DCCK1, MIP4, PARC, SCYA18: Small-inducible cytokine A18 precursor |
GPR44 |
GPR44, CRTH2, DL1R: Putative G-protein coupled receptor 44 |
0.25 |
Evidence |
|
| GDF10 |
GDF10, BMP3B: Bone morphogenetic protein 3b precursor |
AMHR2 |
AMHR2, AMHR: Anti-Muellerian hormone type-2 receptor precursor |
0.25 |
Evidence |
|
| CASP4 |
CASP4, ICH2: Caspase-4 precursor |
AIM2 |
AIM2: AIM2 protein |
0.25 |
Evidence |
|
| MTNR1B |
MTNR1B: Melatonin receptor type 1B |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.25 |
Evidence |
|
| MTNR1B |
MTNR1B: Melatonin receptor type 1B |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.25 |
Evidence |
|
| MTNR1B |
MTNR1B: Melatonin receptor type 1B |
CXCL6 |
CXCL6, GCP2, SCYB6: Small-inducible cytokine B6 precursor |
0.25 |
Evidence |
|
| MTNR1B |
MTNR1B: Melatonin receptor type 1B |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.25 |
Evidence |
|
| MTNR1B |
MTNR1B: Melatonin receptor type 1B |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.25 |
Evidence |
|